Actrapid
RxNorm 253182· ATC A10AB01· insulin, regular, human
KR · 한국Produkte in Korea (39)
- 네오슈린알주(휴먼인슐린)(주)종근당
- 노보렛10/90주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 노보렛10/90주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 노보렛10/90주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 노보렛20/80주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 노보렛20/80주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 노보렛20/80주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 노보렛30/70주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 노보렛30/70주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 노보렛30/70주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 노보렛30/70주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 노보렛30/70주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 노보렛30/70주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 믹스타드30HM주100단위/밀리리터(휴먼인슐린)노보노디스크제약(주)
- 베로슈린HM주100단위/밀리리터(휴먼인슐린)노보노디스크제약(주)
- 베로슈린HM주100단위/밀리리터(휴먼인슐린)노보노디스크제약(주)
- 인슈라타드HM주100단위/밀리리터(휴먼인슐린)노보노디스크제약(주)
- 노보린30/70주100단위/밀리리터(휴먼인슐린)노보노디스크제약(주)
- 액트라피드HM펜필주100단위/밀리리터(휴먼인슐린)노보노디스크제약(주)
- 믹스타드50HM펜필주100단위/밀리리터(휴먼인슐린)노보노디스크제약(주)
- 액트라피드HM주100단위/밀리리터(휴먼인슐린)노보노디스크제약(주)
- 노보렛40/60주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 노보렛50/50주100단위/밀리리터(휴먼인슐린주사액)노보노디스크제약(주)
- 믹스타드20HM펜필주100단위/밀리리터(휴먼인슐린)노보노디스크제약(주)
- 믹스타드10HM펜필주100단위/밀리리터(휴먼인슐린)노보노디스크제약(주)
- 믹스타드40HM펜필주100단위/밀리리터(휴먼인슐린)노보노디스크제약(주)
- 휴물린70/30한국릴리(유)
- 휴물린80/20한국릴리(유)
- 휴물린알주100단위(휴먼인슐린유전자재조합)한국릴리(유)
- 휴물린엔주100단위(휴먼인슐린(유전자재조합)이소판)한국릴리(유)
Chemie (PubChem)
- Summenformel
- C257H383N65O77S6
- Molekülmasse
- 5808 g/mol
- IUPAC-Name
- (4S)-4-[[2-[[(1R,6R,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,50S,53S,56S,59S,62S,65S,68S,71S,74R,77S,80S,83S,88R)-88-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-47-[[(1S)-3-amino-1-carboxy-3-oxopropyl]carbamoyl]-53-(2-amino-2-oxoethyl)-62-(3-amino-3-oxopropyl)-77-[(2S)-butan-2-yl]-24,56-bis(2-carboxyethyl)-83-[(1R)-1-hydroxyethyl]-12,71,80-tris(hydroxymethyl)-33,50,65-tris[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-4-ylmethyl)-27-methyl-18,30,36,59,68-pentakis(2-methylpropyl)-7,10,13,16,19,22,25,28,31,34,37,40,49,52,55,58,61,64,67,70,73,76,79,82,85,87-hexacosaoxo-21,39-di(propan-2-yl)-3,4,44,45,90,91-hexathia-8,11,14,17,20,23,26,29,32,35,38,41,48,51,54,57,60,63,66,69,72,75,78,81,84,86-hexacosazabicyclo[72.11.7]dononacontane-42-carbonyl]amino]acetyl]amino]-5-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[(2S)-2-[[(2S)-6-amino-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
- InChIKey
- PBGKTOXHQIOBKM-FHFVDXKLSA-N